Intrauterine growth restriction and adult disease: The role of adipocytokines

European Journal of Endocrinology

Volumn 160, Issue 3, 2009, Pages 337-347

  Briana, Despina D ^a   Malamitsi Puchner, Ariadne ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; CATECHOLAMINE; GHRELIN; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; SOMATOMEDIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT DISEASE; CHRONIC DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FETAL MALNUTRITION; FETOPLACENTAL UNIT; FETUS MORTALITY; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC RISK; GESTATIONAL AGE; GROWTH RATE; HORMONE RELEASE; HUMAN; INSULIN METABOLISM; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; MATERNAL NUTRITION; METABOLIC DISORDER; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; ADULT; FEMALE; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; RISK FACTOR;

ADIPOKINES; ADULT; CHRONIC DISEASE; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 62649138737     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0621     Document Type: Review

References (159)

1. Rosenberg A. The IUGR newborn. Seminars in Perinatology 2008 32 219-224.
2. Lapillonne A, Braillon P, Claris O, Chatelain PG, Delmas PD & Salle BL. Body composition in appropriate and in small for gestational age infants. Acta Paediatrica 1997 86 196-200.
3. Baum M, Ortiz L & Quan A. Fetal origins of cardiovascular disease. Current Opinion in Pediatrics 2003 15 166-170.
4. Alexander BT. Placental insufficiency leads to development of hypertension in growth-restricted offspring. Hypertension 2003 41 457-462.
5. Hales CN & Ozanne SE. For debate: fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia 2003 46 1013-1019.
6. Barker DJ. Mothers, Babies and Disease in Later Life London: British Medical Journal Publishing, 1984.
7. Rhind SM, Rae MT & Brooks AN. Effects of nutrition and environmental factors on the fetal programming of the reproductive axis. Reproduction 2001 122 205-214.
8. Hales CN & Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992 35 595-601.
9. Barker DJ. In utero programming of chronic disease. Clinical Science 1998 95 115-128.
10. Barker DJ, Eriksson JG, Forsen T & Osmond C. Fetal origins of adult disease: strength of effects and biological basis. International Journal of Epidemiology 2002 31 1235-1239.
11. Barker DJ. Fetal origins of coronary heart disease. BMJ 1995 311 171-174.
12. Osmond C & Barker DJ. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environmental Health Perspectives 2000 108 545-553.
13. Bertram CE & Hanson MA. Animal models and programming of the metabolic syndrome. British Medical Bulletin 2001 60 103-121.
14. Gluckman PD, Hanson MA & Pinal C. The developmental origins of adult disease. Maternal & Child Nutrition 2005 1 130-141.
15. Hattersley AT & Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999 353 1789-1792.
16. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI & Cohen D. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. New England Journal of Medicine 1993 328 679-702.
17. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R & Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature Genetics 1998 19 268-270.
18. Fowden AL & Forhead AJ. Endocrine mechanisms of intrauterine programming. Reproduction 2004 127 515-526.
19. Fowden AL, Giussani DA & Forhead AJ. Endocrine and metabolic programming during intrauterine development. Early Human Development 2005 81 723-734.
20. Phillips DI. Fetal growth and programming of the hypothalamic- pituitary-adrenal axis. Clinical and Experimental Pharmacology and Physiology 2001 28 967-970.
21. Jaquet D, Gaboriau A, Czernichow P & Levy-Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. Journal of Clinical Endocrinology and Metabolism 2000 85 1401-1406.
22. Eriksson J, Forsen T, Tuomilehto J, Osmond C & Barker D. Size at birth, childhood growth and obesity in adult life. International Journal of Obesity and Related Metabolic Disorders 2001 25 735-740.
23. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C & Barker DJ. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 1999 318 427-431.
24. Soto N, Bazaes RA, Pena V, Salazar T, Avila A, Iniguez G, Ong KK, Dunger DB & Mericq MV. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. Journal of Clinical Endocrinology and Metabolism 2003 88 36453650.
25. Veening MA, Van Weissenbruch MM & Delemarre-Van De Waal HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. Journal of Clinical Endocrinology and Metabolism 2002 87 4657-4661.
26. Saenger P, Czernichow P, Hughes I & Reiter EO. Small for gestational age: short stature and beyond. Endocrine Reviews 2007 28 219-251.
27. Colle E, Schiff D, Andrew G, Bauer CB & Fitzhardinge P. Insulin responses during catch-up growth of infants who were small for gestational age. Pediatrics 1976 57 363-371.
28. Ong KK & Dunger DB. Birth weight, infant growth and insulin resistance. European Journal of Endocrinology 2004 151 U131-U139.
29. Jaquet D, Deghmoun S, Chevenne D, Collin D, Czernichow P & Lévy-Marchal C. Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia 2005 48 849-855.
30. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991 14 1132-1143.
31. Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA, Deshpande SS, Joglekar CV & Yudkin JS. Adiposity and hyperinsulinemia in Indians are present at birth. Journal of Clinical Endocrinology and Metabolism 2002 87 5575-5580.
32. Ibanez L, Lopez-Bermejo A, Suarez L, Marcos MV, Diaz M & de Zegher F. Visceral adiposity without overweight in children born small for gestational age. Journal of Clinical Endocrinology and Metabolism 2008 93 2079-2083.
33. Boiko J, Jaquet D, Chevenne D, Rigal O, Czernichow P & Levy- Marchal C. In situ lipolytic regulation in subjects born small for gestational age. International Journal of Obesity 2005 29 565-570.
34. Eriksson JG, Lindi V, Uusitupa M, Forsen TJ, Laakso M, Osmond C & Barker DJ. The effects of the Pro12Ala polymorphism of the peroxisome proliferators-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes 2002 51 2321-2324.
35. Hoggard N, Hoggarty P, Thomas L & Lea RG. Leptin expression in placental and fetal tissues: does leptin have a functional role? Biochemical Society Transactions 2001 29 57-62.
36. Christou H, Serdy S & Mantzoros CS. Leptin in relation to growth and developmental processes in the fetus. Seminars in Reproductive Medicine 2002 20 123-130.
37. Christou H, Connors JM, Ziotopoulou M, Hatzidakis V, Papathanassoglou E, Ringer SA & Mantzoros CS. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. Journal of Clinical Endocrinology and Metabolism 2001 86 935-938.
38. Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Schiff E & Sivan E. Cord blood adiponectin in large-for-gestational age newborns. American Journal of Obstetrics and Gynecology 2005 193 1238-1242.
39. Kitamura S, Yokota I, Hosoda H, Kotani Y, Matsuda J, Naito E, Ito M, Kangawa K & Kuroda Y. Ghrelin concentration in cord and neonatal blood: relation to fetal growth and energy balance. Journal of Clinical Endocrinology and Metabolism 2003 88 5473-5477.
40. Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P & Spada A. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clinical Endocrinology 2007 66 447-453.
41. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 425-432.
42. Auwerx J & Staels B. Leptin. Lancet 1998 351 737-742.
43. Ahima RS & Flier JS. Leptin. Annual Review of Physiology 2000 62 413-437.
44. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB & O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997 387 903-908.
45. Krechowec SO, Vickers M, Gertler A & Breier BH. Prenatal influences on leptin sensitivity and susceptibility to diet-induced obesity. Journal of Endocrinology 2006 189 355-363.
46. Alexe DM, Syridou G & Petridou ET. Determinants of early life leptin levels and later life degenerative outcomes. Clinical Medicine & Research 2006 4 326-335.
47. Reitman ML, Bi S, Marcus-Samuels B & Gavrilova O. Leptin and its role in pregnancy and fetal development: an overview. Biochemical Society Transactions 2001 29 68-72.
48. Mostyn A, Keisler DH, Webb R, Stephenson T & Symonds ME. The role of leptin in the transition from fetus to neonate. Proceedings of the Nutrition Society 2001 60 187-194.
49. Hassink SG, de Lancey E, Sheslow DV, Smith-Kirwin SM, O'Connor DM, Considine RV, Opentanova I, Dostal K, Spear ML, Leef K, Ash M, Spitzer AR & Funanage VL. Placental leptin: an important new growth factor in intrauterine and neonatal development? Pediatrics 1997 100 E1.
50. Clapp JF III & Kiess W. Cord blood leptin reflects fetal fat mass. Journal of the Society for Gynecologic Investigation 1998 5 300-303.
51. Geary M, Herschkovitz R, Pringle PJ, Rodeck CH & Hindmarsh PC. Ontogeny of serum leptin concentrations in the human. Clinical Endocrinology 1999 51 189-192.
52. Tsai PJ, Yu CH, Hsu SP, Lee YH, Chiou CH, Hsu YW, Ho SC & Chu CH. Cord plasma concentrations of adiponectin and leptin in healthy term neonates: positive correlation with birthweight and neonatal adiposity. Clinical Endocrinology 2004 61 88-93.
53. Geary M, Pringle PJ, Persaud M, Wilshin J, Hindmarsh PC, Rodeck CH & Brook CG. Leptin concentrations in maternal serum and cord blood: relationship to maternal anthropometry and fetal growth. British Journal of Obstetrics and Gynaecology 1999 106 1054-1060.
54. Javaid MK, Godfrey KM, Taylor P, Robinson SM, Crozier SR, Dennison EM, Robinson JS, Breier BR, Arden NK & Cooper C. Umbilical cord leptin predicts neonatal bone mass. Calcified Tissue International 2005 76 341-347.
55. McMillen IC, Muhlhausler BS, Duffield JA & Yuen BS. Prenatal programming of postnatal obesity: fetal nutrition and the regulation of leptin synthesis and secretion before birth. Proceedings of the Nutrition Society 2004 63 405-412.
56. Yuen BS, Owens PC, Muhlhausler BS, Roberts CT, Symonds ME, Keisler DH, McFarlane JR, Kauter KG, Evens Y & McMillen IC. Leptin alters the structural and functional characteristics of adipose tissue before birth. FASEB Journal 2003 17 1102-1104.
57. Yarbrough DE, Barrett-Connor E & Morton DJ. Birth weight as a predictor of adult bone mass in postmenopausal women: the Rancho Bernardo Study. Osteoporosis International 2000 11 626-630.
58. Pighetti M, Tommaselli GA, D'Elia A, Di Carlo C, Mariano A, Di Carlo A & Nappi C. Maternal serum and umbilical cord blood leptin concentrations with fetal growth restriction. Obstetrics and Gynecology 2003 102 535-543.
59. Yildiz L, Avci B & Ingec M. Umbilical cord and maternal blood leptin concentrations in intrauterine growth retardation. Clinical Chemistry and Laboratory Medicine 2002 40 1114-1117.
60. Varvarigou A, Mantzoros CS & Beratis NG. Cord blood leptin concentration in relation to intrauterine growth. Clinical Endocrinology 1999 50 177-183.
61. Jaquet D, Leger J, Levy-Marchal C, Oury JF & Czernichow P. Ontogeny of leptin in human fetuses and newborns: effect of intrauterine growth retardation on serum leptin concentrations. Journal of Clinical Endocrinology and Metabolism 1998 83 1243-1246.
62. Arslan M, Yazici G, Erdem A, Erdem M, Arslan EO & Himmetoglu O. Endothelin 1 and leptin in the pathophysiology of intrauterine growth restriction. International Journal of Gynaecology and Obstetrics 2004 84 120-126.
63. Koistinen HA, Koivisto VA, Andersson S, Karonen SL, Kontula K, Oksanen L & Teramo KA. Leptin concentration in cord blood correlates with intrauterine growth. Journal of Clinical Endocrinology and Metabolism 1997 82 3328-3330.
64. Cetin I, Morpurgo PS, Radaelli T, Taricco E, Cortellazzi D, Bellotti M, Pardi G & Beck-Peccoz P. Fetal plasma leptin concentrations: relationship with different intrauterine growth patterns from 19 weeks to term. Pediatric Research 2000 48 646-651.
65. Lepercq J, Challier JC, Guerre-Millo M, Cauzac M, Vidal H & Hauguel-de Mouzon S. Prenatal leptin production: evidence that fetal adipose tissue produces leptin. Journal of Clinical Endocrinology and Metabolism 2001 86 2409-2413.
66. Tamura T, Goldenberg RL, Johnson KE & Cliver SP. Serum leptin concentrations during pregnancy and their relationship to fetal growth. Obstetrics and Gynecology 1998 91 389-395.
67. Marchini G, Fried G, Ostlund E & Hagenas L. Plasma leptin in infants: relations to birth weight and weight loss. Pediatrics 1998 101 429-432.
68. Koklu E, Ozturk MA, Kurtoglu S, Akcakus M, Yikilmaz A & Gunes T. Aortic intima-media thickness, serum IGF-I, IGFBP-3, and leptin levels in intrauterine growth-restricted newborns of healthy mothers. Pediatric Research 2007 62 704-709.
69. Matsuda J, Yokota I, Iida M, Murakami T, Naito E, Ito M, Shima K & Kuroda Y. Serum leptin concentration in cord blood: relationship to birth weight and gender. Journal of Clinical Endocrinology and Metabolism 1997 82 1642-1644.
70. Shaarawy M & el-Mallah SY. Leptin and gestational weight gain: relation of maternal and cord blood leptin to birth weight. Journal of the Society for Gynecologic Investigation 1999 6 70-73.
71. Martinez-Cordero C, Amador-Licona N, Guizar-Mendoza JM, Hernandez-Mendez J & Ruelas-Orozco G. Body fat at birth and cord blood levels of insulin, adiponectin, leptin, and insulin-like growth factor-I in small-for-gestational-age infants. Archives of Medical Research 2006 37 490-494.
72. Valuniene M, Verkauskiene R, Boguszewski M, Dahlgren J, Lasiene D, Lasas L & Wikland KA. Leptin levels at birth and in early postnatal life in small- and appropriate-for-gestational-age infants. Medicina 2007 43 784-791.
73. Lea RG, Howe D, Hannah LT, Bonneau O, Hunter L & Hoggard N. Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. Molecular Human Reproduction 2000 6 763-769.
74. Lepercq J, Guerre-Millo M, Andre J, Cauzac M & Hauguel-de Mouzon S. Leptin: a potential marker of placental insufficiency. Gynecologic and Obstetric Investigation 2003 55 151-155.
75. Ben X, Qin Y, Wu S, Zhang W & Cai W. Placental leptin correlates with intrauterine fetal growth and development. Chinese Medical Journal 2001 114 636-639.
76. Jaquet D, Leger J, Tabone MD, Czernichow P & Levy-Marchal C. High serum leptin concentrations during catch-up growth of children born with intrauterine growth retardation. Journal of Clinical Endocrinology and Metabolism 1999 84 1949-1953.
77. Ong KK, Ahmed ML, Sherriff A, Woods KA, Watts A, Golding J & Dunger DB. Cord blood leptin is associated with size at birth and predicts infancy weight gain in humans. Journal of Clinical Endocrinology and Metabolism 1999 84 1145-1148.
78. Phillips DI, Fall CH, Cooper C, Norman RJ, Robinson JS & Owens PC. Size at birth and plasma leptin concentrations in adult life. International Journal of Obesity and Related Metabolic Disorders 1999 23 1025-1029.
79. Stocker CJ, Arch JR & Cawthorne MA. Fetal origins of insulin resistance and obesity. Proceedings of the Nutrition Society 2005 64 143-151.
80. Kyriakakou M, Malamitsi-Puchner A, Militsi H, Boutsikou T, Margeli A, Hassiakos D, Kanaka-Gantenbein C, Papassotiriou I & Mastorakos G. Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates and their mothers. European Journal of Endocrinology 2008 158 343-348.
81. Shekawat PS, Garland JS, Shivpuri C, Mick GJ, Sasidharan P, Pelz CJ & McCormick KL. Neonatal cord blood leptin: its relationship to birth weight, body mass index, maternal diabetes, and steroids. Pediatric Research 1998 43 338-343.
82. Grosfeld A, Andre J, Hauguel-De Mouzon SH, Berrat E, Pouyssegur J & Guerre-Millo M. Hypoxia-induced factor 1 transactivates the human leptin gene promoter. Journal of Biological Chemistry 2002 277 42953-42957.
83. Stocker C, O'Dowd J, Morton NM, Wargent E, Sennitt MV, Hislop D, Glund S, Seckl JR, Arch JR & Cawthorne MA. Modulation of susceptibility to weight gain and insulin resistance in low birthweight rats by treatment of their mothers with leptin during pregnancy and lactation. International Journal of Obesity and Related Metabolic Disorders 2004 28 129-136.
84. Stocker C, Wargent E, Sennitt M, Nolan A, O'Dowd J, Subramaniam K, Wang S & Cawthorne MA. Maternal leptin administration induces resistance to diet-induced obesity of early growth restricted rats. Diabetologia 2001 44 641.
85. Vickers MH, Breier BH, Cutfield WS, Hofman PL & Gluckman PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. American Journal of Physiology. Endocrinology and Metabolism 2000 279 E83-E87.
86. Nusken KD, Dotsch J, Rauh M, Rascher W & Schneider H. Uteroplacental insufficiency after bilateral uterine artery ligation in the rat: impact on postnatal glucose and lipid metabolism and evidence for metabolic programming of the offspring by sham operation. Endocrinology 2008 149 1056-1063.
87. Krechowec SO, Vickers M, Gertler A & Breier BH. Prenatal influences on leptin sensitivity and susceptibility to diet-induced obesity. Journal of Endocrinology 2006 189 355-363.
88. Sugden MC, Langdown ML, Munns MJ & Holness MJ. Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension aassociated with hyperleptinaemia in the early-growth-retarded adult offspring. European Journal of Endocrinology 2001 145 529-539.
89. Vickers MH, Reddy S, Ikenasio BA & Breier BH. Dysregulation of the adipoinsular axis - a mechanism for the pathogenesis of hyperleptinemia and adipogenic diabetes induced by fetal programming. Journal of Endocrinology 2001 170 323-332.
90. Holness MJ. Enhanced glucose uptake into adipose tissue induced by early growth restriction augments excursions in plasma leptin response evoked by changes in insulin status. International Journal of Obesity and Related Metabolic Disorders 2001 25 1775-1781.
91. Desai M, Gayle D, Babu J & Ross MG. Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2005 288 91-96.
92. Desai M, Gayle D, Han G & Ross MG. Programmed hyperphagia due to reduced anorexigenic mechanisms in intrauterine growth-restricted offspring. Reproductive Sciences 2007 14 329-337.
93. Delahaye F, Breton C, Risold PY, Enache M, Dutriez-Casteloot I, Laborie C, Lesage J & Vieau D. Maternal perinatal undernutrition drastically reduces postnatal leptin surge and affects the development of arcuate nucleus proopiomelanocortin neurons in neonatal male rat pups. Endocrinology 2008 149 470-475.
94. Buchbinder A, Lang U, Baker RS, Khoury JC, Mershon J & Clark KE. Leptin in the ovine fetus correlates with fetal and placental size. American Journal of Obstetrics and Gynecology 2001 185 786-791.
95. Attig L, Djiane J, Gertler A, Rampin O, Larcher T, Boukthir S, Anton P, Madec JY, Gourdou I & Abdennebi-Najar L. Study of hypothalamic leptin receptor expression in low birth weight piglets and effects of leptin supplementation on neonatal growth and development. American Journal of Physiology. Endocrinology and Metabolism 2008 295 E1117-E1125.
96. Ehrhardt RA, Bell AW & Boisclair YR. Spatial and developmental regulation of leptin in fetal sheep. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2002 282 R1628-R1635.
97. Yuen BS, Owens PC, McFarlane JR, Symonds ME, Edwards LJ, Kauter KG & McMillen IC. Circulating leptin concentrations are positively related to leptin messenger RNA expression in the adipose tissue of fetal sheep in the pregnant ewe fed at or below maintenance energy requirements during late gestation. Biology of Reproduction 2002 67 911-916.
98. Berg AH, Combs TP & Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinology and Metabolism 2002 13 84-89.
99. Schondorf T, Maiworm A, Emmison N, Forst T & Pfutzner A. Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk. Clinical Laboratory 2005 51 489-494.
100. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE & Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001 86 1930-1935.
101. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okudo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T & Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 79-83.
102. Fantuzzi G. Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology 2005 115 911-919.
103. Lindsay RS, Walker JD, Havel PJ, Hamilton BA, Calder AA & Johnstone FD. Adiponectin is present in cord blood but is unrelated to birth weight. Diabetes Care 2003 26 2244-2249.
104. Pardo I, Geloneze B, Tambascia MA & Barros-Filho AA. Hyperadiponectinemia in newborns: relationship with leptin levels and birth weight. Obesity Research 2004 12 521-524.
105. Caminos JE, Noguerias R, Gallego R, Bravo S, Tovar S, Garcia-Caballero T, Casanueva FF & Dieguez C. Expression and regulation of adiponectin and receptor in human and rat placenta. Journal of Clinical Endocrinology and Metabolism 2005 90 4276-4286.
106. Kotani Y, Yokota I, Kitamura S, Matsuda J, Naito E & Kuroda Y. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clinical Endocrinology 2004 61 418-423.
107. Sivan E, Mazaki-Tovi S, Pariente C, Efraty Y, Schiff E, Hemi R & Kanety H. Adiponectin in human cord blood: relation to fetal birth weight and gender. Journal of Clinical Endocrinology and Metabolism 2003 88 5656-5660.
108. Fant ME & Weisoly D. Insulin and insulin-like growth factors in human development: implications for the perinatal period. Seminars in Perinatology 2001 25 426-435.
109. Ibanez L, Sebastiani G, Lopez-Bermejo A, Diaz M, Gomez-Roig MD & de Zegher F. Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth. Journal of Clinical Endocrinology and Metabolism 2008 93 2774-2778.
110. Kamoda T, Saitoh H, Saito M, Sugiura M & Matsui A. Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatric Research 2004 56 690-693.
111. Takaya J, Yamato F, Higashino H & Kaneko K. Intracellular magnesium and adipokines in umbilical cord plasma and infant birth size. Pediatric Research 2007 62 700-703.
112. Cianfarani S, Martinez C, Maiorana A, Scire G, Spadoni GL & Boemi S. Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal catch-up growth. Journal of Clinical Endocrinology and Metabolism 2004 89 1346-1351.
113. Sancakli O, Darendeliler F, Bas F, Gokcay G, Disci R, Aki S & Eskiyurt N. Insulin, adiponectin, IGFBP-1 levels and body composition in small for gestational age born non-obese children during prepubertal ages. Clinical Endocrinology 2008 69 88-92.
114. Lopez-Bermejo A, Casano-Sancho P, Fernandez-Real JM, Kihara S, Funahashi T, Rodriguez-Hierro F, Ricart W & Ibanez L. Both intrauterine growth restriction and postnatal growth influence childhood serum concentrations of adiponectin. Clinical Endocrinology 2004 61 339-346.
115. Iniguez G, Soto N, Avila A, Salazar T, Ong K, Dunger D & Mericq V. Adiponectin levels in the first two years of life in a prospective cohort: relations with weight gain, leptin levels and insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2004 89 5500-5503.
116. Chen L & Nyomba BL. Glucose intolerance and resistin expression in rat offspring exposed to ethanol in utero: modulation by postnatal high-fat diet. Endocrinology 2003 144 500-508.
117. Evagelidou EN, Giapros VI, Challa AS, Kiortsis DN, Tsatsoulis AA & Andronikou SK. Serum adiponectin levels, insulin resistance, and lipid profile in children born small for gestational age are affected by the severity of growth retardation at birth. European Journal of Endocrinology 2007 156 271-277.
118. Lopez-Bermejo A. Insulin resistance after prenatal growth restriction: is it mediated by adiponectin deficiency? Clinical Endocrinology 2006 64 479-480.
119. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from the stomach. Nature 1999 402 656-660.
120. Gualillo O, Caminos J, Blanco M, Garcia-Caballero T, Kojima M, Kangawa K, Dieguez C & Casanueva F. Ghrelin, a novel placental-derived hormone. Endocrinology 2001 142 788-794.
121. Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M & Ghigo E. Neuroendocrine and peripheral activities of ghrelin. Implications in metabolism and obesity. European Journal of Pharmacology 2002 440 235-254.
122. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K & Nakao K. Ghrelin strongly stimulates growth hormone release in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 4908-4911.
123. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K & Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001 409 194-198.
124. Ng PC, Lee CH, Lam CW, Chan IH, Wong E & Fok TF. Ghrelin in preterm and term newborns: relation to anthropometry, leptin and insulin. Clinical Endocrinology 2005 63 217-222.
125. Farquhar J, Heiman M, Wong AC, Wach R, Chessex P & Chanoine JP. Elevated umbilical cord ghrelin concentrations in small for gestational age neonates. Journal of Clinical Endocrinology and Metabolism 2003 88 4324-4327.
126. Onal EE, Cinaz P, Atalay Y, Turkyilmaz C, Bideci A, Akturk A, Okumus N, Unal S, Koc E & Ergenekon E. Umbilical cord ghrelin concentrations in small- and appropriate-for-gestational age newborn infants: relationship to anthropometric markers. Journal of Endocrinology 2004 180 267-271.
127. Cance-Rouzaud A, Laborie S, Bieth E, Tricoire J, Rolland M, Grandjean H, Rochiccioli P & Tauber M. Growth hormone, insulin-like growth factor-I and insulin-like growth factor binding protein-3 are regulated differently in small-for-gestational-age and appropriate-for-gestational-age neonates. Biology of the Neonate 1998 73 347-355.
128. Mendez-Ramirez F, Barbosa-Sabanero G, Romero-Gutierrez G & Malacara JM. Ghrelin in small for gestational age newborn babies: a cross-sectional study. Clinical Endocrinology 2009 70 41-46.
129. Iniguez G, Ong K, Pena V, Avila A, Dunger D & Mericq V. Fasting and post-glucose ghrelin levels in SGA infants: relationships with size and weight gain at one year of age. Journal of Clinical Endocrinology and Metabolism 2002 87 5830-5833.
130. Pickup JC, Chusney GD, Thomas SM & Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sciences 2000 67 291-300.
131. Kameda T, Matsuzaki N, Sawai K, Okada T, Saji F, Matsuda T, Hirano T, Kishimoto T & Tanizawa O. Production of interleukin-6 by normal human trophoblast. Placenta 1990 11 205-213.
132. Opsjon SL, Austgulen R & Waage A. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders. Acta Obstetricia et Gynecologica Scandinavica 1995 74 19-26.
133. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Vefring H & Austgulen R. Umbilical cord plasma interleukin-6 and fetal growth restriction in preeclampsia: a prospective study in Norway. Obstetrics and Gynecology 2001 98 289-294.
134. Street ME, Seghini P, Fieni S, Ziveri MA, Volta C, Martorana D, Viani I, Gramellini D & Bernasconi S. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. European Journal of Endocrinology 2006 155 567-574.
135. Schiff E, Friedman SA, Baumann P, Sibai BM & Romero R. Tumor necrosis factor-alpha in pregnancies associated with preeclampsia or small-for-gestational-age newborns. American Journal of Obstetrics and Gynecology 1994 170 1224-1229.
136. Fernandez-Real JM & Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/ phenotype to thriftiness. Diabetologia 1999 42 1367-1374.
137. Jefferies CA, Hofman PL, Keelan JA, Robinson EM & Cutfield WS. Insulin resistance is not due to persistently elevated serum tumor necrosis-alpha levels in small for gestational age, premature, or twin children. Pediatric Diabetes 2004 5 20-25.
138. Casano-Sancho P, Lopez-Bermejo A, Fernandez-Real JM, Monros E, Valls C, Rodriguez-Gonzalez FX, Ricart W & Ibanez L. The tumour necrosis factor (TNF)-alpha-308GA promoter polymorphism is related to prental growth and postnatal insulin resistance. Clinical Endocrinology 2006 64 129-135.
139. Briana DD, Boutsikou M, Baka S, Gourgiotis D, Marmarinos A, Hassiakos D & Malamitsi-Puchner A. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Neonatology 2008 93 153-157.
140. Malamitsi-Puchner A, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D & Briana DD. Circulating apelin concentrations in mother/infant pairs at term. Acta Paediatrica 2007 96 1751-1754.
141. Malamitsi-Puchner A, Briana DD, Gourgiotis D, Boutsikou M, Baka S & Hassiakos D. Blood visfatin concentrations in normal full-term pregnancies. Acta Paediatrica 2007 96 526-529.
142. Briana DD, Boutsikou M, Gourgiotis D, Kontara L, Baka S, Iacovidou N, Hassiakos D & Malamitsi-Puchner A. Role of visfatin, insulin-like growth factor-I and insulin in fetal growth. Journal of Perinatal Medicine 2007 35 326-329.
143. Malamitsi-Puchner A, Briana DD, Boutsikou M, Kouskouni E, Hassiakos D & Gourgiotis D. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007 119 E1314-E1318.
144. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS & Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001 409 307-312.
145. Steppan CM & Lazar MA. Resistin and obesity-associated insulin resistance. Trends in Endocrinology and Metabolism 2002 13 18-23.
146. Yura S, Sagawa N, Itoh H, Kakui K, Nuamah MA, Korita D, Takemura M & Fujii S. Resistin is expressed in the human placenta. Journal of Clinical Endocrinology and Metabolism 2003 88 1394-1397.
147. Caja S, Martinez I, Abelenda M & Puerta M. Resistin expression and plasma concentration peak at different times during pregnancy in rats. Journal of Endocrinology 2005 185 551-559.
148. Ng PC, Lee CH, Lam CW, Chan IH, Wong E & Fok TF. Resistin in preterm and term newborns: relation to anthropometry, leptin, and insulin. Pediatric Research 2005 58 725-730.
149. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H & Fujino M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochemical and Biophysical Research Communications 1998 251 471-476.
150. De Falco M, De Luca L, Onori N, Cavallotti I, Artigiano F, Esposito V, De Luca B, Laforgia V, Groeger AM & De Luca A. Apelin expression in normal human tissues. In Vivo 2002 16 333-336.
151. Cox CM, D'Agostino SL, Miller MK, Heimark RL & Krieg PA. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Developmental Biology 2006 296 177-189.
152. Cobellis L, De Falco M, Mastrogiacomo A, Giraldi D, Dattilo D, Scaffa C,
153. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpene C, Audigier Y, Saulnier-Blache JS & Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005 146 1764-1771.
154. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H & Li K. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Experimental and Clinical Endocrinology and Diabetes 2006 114 544-548.
155. Samal B, Sun Y, Stearns G, Xie C, Suggs S & McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology 1994 14 1431-1437.
156. Sethi JK & Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends in Molecular Medicine 2005 11 344-347.
157. Arner P. Visfatin - a true or false trail to type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2006 91 28-30.
158. Stephens JM & Vidal-Puig AJ. An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity. Current Opinion in Lipidology 2006 17 128-131.
159. Ognjanovic S & Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. American Journal of Obstetrics and Gynecology 2002 187 1051-1058.